17th Annual Multicenter Merkel Interest Group (MMIG) Meeting
February 3, 2023
The MCC Multi-center Merkel Interest Group will be hosting our 17th Annual Multi-center Merkel Interest Group meeting on Friday, March 17, 2023 from 5-7 p.m. CDT. Attendees may join in-person at the Hilton New Orleans Riverside Downtown Hotel, Fulton Room, in New Orleans, La. or virtually over Zoom. This event runs concurrently with the 2023 AAD Annual Meeting, happening March 17-21, 2023, in New Orleans, La.
The MCC Multi-center Merkel Interest Group is an international collection of clinicians, scientists, and trainees across various medical institutions who are dedicated to improving MCC patient care by studying this disease and sharing data.
RSVP & Mailing List
If you are interested in attending this meeting, and/or would like be added to the Merkel Interest Group mailing list to receieve information on future events, please email Krista Lachance, Research Manager, [email protected].
Agenda (Times in CDT)
| 5:00-5:10pm | Welcome & Overview of Meeting | Paul Nghiem, MD/PhD (University of Washington) |
| 5:10-5:25pm | Margin Status and the Role of Adjuvant Radiation in MCC: The Australian Experience | David Kok, MBBS/MEd
(Peter MacCallum Cancer Centre) |
| 5:25-5:40pm
|
Virus Positive MCC in Skin of Color and Impact on Disease Outcomes
|
Mackenzie Martin, BA
(Brownell Lab, NIH/NIAMS) |
| 5:40-5:55pm
|
Clinical Trial Updates for MCC | Erin McClure, BS &
Neha Singh, BS (University of Washington) |
| 5:55-6:00pm | BREAK | |
| 6:00-6:15pm
|
An Emerging Radiotherapy Option for MCC Patients: 8 Gray Single Fraction | Emily Huynh, BS
(University of Washington) |
| 6:15-6:30pm
|
Baseline MCC Imaging with Ultrasound and PET/CT: A Comparison | Lisanne Zijlker, PhD candidate (Melanoma Institute Australia) |
| 6:30-6:45pm | Utility of Circulating Tumor DNA to Monitor Treatment Response and Recurrence | Lisa Zaba, MD/PhD
(Stanford University) & Tomoko Aikaike, MD (University of Washington) |
| 6:45-6:55pm | SATB2, CKAE1/AE3, and synaptophysin as a sensitive immunohistochemical panel for the detection of lymph node metastases of MCC – a multicenter study | Anna Szumera-Ciećkiewicz, MD/PhD (Maria Sklodowska-Curie National Research Institute of Oncology)
& Piotr Donizy, MD/PhD (Wroclaw Medical University)* |
| 6:55-7:00pm | Closing remarks | Paul Nghiem, MD/PhD
(University of Washington) |